112.79
price down icon0.15%   -0.0832
 
loading
前日終値:
$112.71
開ける:
$112.63
24時間の取引高:
694.83K
Relative Volume:
0.10
時価総額:
$139.96B
収益:
$28.80B
当期純損益:
$6.31B
株価収益率:
22.47
EPS:
5.02
ネットキャッシュフロー:
$9.37B
1週間 パフォーマンス:
-1.21%
1か月 パフォーマンス:
-0.56%
6か月 パフォーマンス:
-2.97%
1年 パフォーマンス:
+41.21%
1日の値動き範囲:
Value
$112.15
$113.05
1週間の範囲:
Value
$111.28
$113.85
52週間の値動き範囲:
Value
$77.74
$121.83

Gilead Sciences Inc Stock (GILD) Company Profile

Name
名前
Gilead Sciences Inc
Name
セクター
Healthcare (1155)
Name
電話
(650) 574-3000
Name
住所
333 LAKESIDE DR, FOSTER CITY, CA
Name
職員
17,600
Name
Twitter
@GileadSciences
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
GILD's Discussions on Twitter

GILD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
GILD
Gilead Sciences Inc
112.80 140.17B 28.80B 6.31B 9.37B 5.02
Drug Manufacturers - General icon
LLY
Lilly Eli Co
736.89 656.73B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
176.91 426.69B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
212.00 371.68B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
127.70 244.98B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
85.06 210.11B 63.43B 16.42B 14.72B 6.49

Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-19 アップグレード Daiwa Securities Neutral → Outperform
2025-08-08 アップグレード Truist Hold → Buy
2025-07-25 アップグレード Needham Hold → Buy
2025-04-22 再開されました Cantor Fitzgerald Overweight
2025-03-04 繰り返されました Oppenheimer Outperform
2025-02-18 アップグレード Deutsche Bank Hold → Buy
2025-02-13 アップグレード DZ Bank Hold → Buy
2025-01-10 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-12-10 再開されました BofA Securities Buy
2024-11-15 開始されました Wolfe Research Outperform
2024-11-14 開始されました Citigroup Buy
2024-11-08 ダウングレード Maxim Group Buy → Hold
2024-10-21 アップグレード Leerink Partners Market Perform → Outperform
2024-10-17 開始されました Bernstein Outperform
2024-10-07 アップグレード Wells Fargo Equal Weight → Overweight
2024-07-08 アップグレード Raymond James Mkt Perform → Outperform
2024-05-01 繰り返されました Maxim Group Buy
2024-04-24 アップグレード HSBC Securities Reduce → Hold
2024-02-22 ダウングレード Truist Buy → Hold
2023-11-09 開始されました Deutsche Bank Hold
2023-09-08 アップグレード BofA Securities Neutral → Buy
2023-09-06 開始されました HSBC Securities Reduce
2023-07-24 繰り返されました Barclays Equal Weight
2023-05-16 アップグレード BMO Capital Markets Market Perform → Outperform
2023-04-28 再開されました Piper Sandler Overweight
2023-01-03 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-12-13 再開されました BofA Securities Neutral
2022-12-09 ダウングレード DZ Bank Buy → Hold
2022-10-31 アップグレード Barclays Underweight → Equal Weight
2022-10-28 繰り返されました BMO Capital Markets Market Perform
2022-10-28 繰り返されました Cowen Outperform
2022-10-28 繰り返されました JP Morgan Overweight
2022-10-28 繰り返されました Jefferies Buy
2022-10-28 アップグレード Piper Sandler Neutral → Overweight
2022-10-28 繰り返されました RBC Capital Mkts Outperform
2022-10-28 アップグレード Truist Hold → Buy
2022-10-28 繰り返されました Wells Fargo Equal Weight
2022-10-04 アップグレード JP Morgan Neutral → Overweight
2022-07-13 開始されました Cantor Fitzgerald Neutral
2022-05-23 開始されました SVB Leerink Mkt Perform
2022-02-28 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-02-02 繰り返されました BMO Capital Markets Outperform
2022-02-02 繰り返されました BofA Securities Neutral
2022-02-02 繰り返されました RBC Capital Mkts Outperform
2022-02-02 繰り返されました Truist Hold
2022-02-02 繰り返されました Wells Fargo Equal Weight
2022-01-28 アップグレード Argus Hold → Buy
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-12-09 再開されました Wells Fargo Equal Weight
2021-12-06 開始されました Goldman Neutral
2021-11-19 アップグレード BMO Capital Markets Market Perform → Outperform
2021-11-19 再開されました Piper Sandler Neutral
2021-10-20 再開されました Cowen Outperform
2021-07-30 繰り返されました BMO Capital Markets Market Perform
2021-07-30 繰り返されました RBC Capital Mkts Outperform
2021-04-01 アップグレード Bernstein Mkt Perform → Outperform
2021-03-30 アップグレード Redburn Neutral → Buy
2021-01-19 アップグレード Morgan Stanley Equal-Weight → Overweight
2021-01-04 アップグレード Guggenheim Neutral → Buy
2020-11-03 再開されました Morgan Stanley Equal-Weight
2020-10-28 開始されました UBS Neutral
2020-09-30 再開されました Jefferies Buy
2020-09-15 アップグレード Maxim Group Hold → Buy
2020-07-31 繰り返されました Credit Suisse Neutral
2020-07-31 繰り返されました Morgan Stanley Equal-Weight
2020-07-31 繰り返されました Piper Sandler Overweight
2020-07-31 繰り返されました RBC Capital Mkts Outperform
2020-07-31 繰り返されました SunTrust Hold
2020-07-31 繰り返されました Wells Fargo Equal Weight
2020-07-20 アップグレード Credit Suisse Underperform → Neutral
2020-06-03 アップグレード SVB Leerink Mkt Perform → Outperform
2020-05-26 アップグレード SunTrust Sell → Hold
2020-05-01 ダウングレード JP Morgan Overweight → Neutral
2020-05-01 ダウングレード Raymond James Outperform → Mkt Perform
2020-05-01 ダウングレード SunTrust Hold → Sell
2020-04-27 ダウングレード UBS Buy → Neutral
2020-04-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2020-04-20 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 ダウングレード CFRA Hold → Sell
すべてを表示

Gilead Sciences Inc (GILD) 最新ニュース

pulisher
07:57 AM

Intraday pattern recognizer results for Gilead Sciences Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser

07:57 AM
pulisher
03:52 AM

How hedge fund analytics apply to Gilead Sciences Inc. stockTake Profit & Growth Oriented Trade Recommendations - Newser

03:52 AM
pulisher
02:15 AM

What earnings revisions data tells us about Gilead Sciences Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser

02:15 AM
pulisher
01:46 AM

Using RSI to spot recovery in Gilead Sciences Inc.2025 Retail Activity & High Return Stock Watch Alerts - Newser

01:46 AM
pulisher
01:46 AM

Stock Analysis | Gilead Sciences OutlookA Strong Technical Picture Amid Mixed Analyst Sentiment - AInvest

01:46 AM
pulisher
12:25 PM

What to expect from Gilead Sciences Inc. in the next 30 daysQuarterly Profit Review & Low Risk Entry Point Guides - Newser

12:25 PM
pulisher
Sep 02, 2025

Gilead's $0.5B Volume Ranks 215th as Q2 Sales Climb and Yeztugo Approval Signals Long-Term Innovation - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Market Trends: Can Gilead Sciences Inc. grow without external funding2025 Winners & Losers & Consistent Income Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Gilead eyes price hikes for HIV meds in state AIDS programs - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

What Do Analysts Think About Gilead Sciences (GILD)? - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

Gilead Sciences - Fierce Pharma

Sep 02, 2025
pulisher
Sep 02, 2025

Gilead Sciences: HIV Leadership Outshines Decline In COVID-19 Drug Sales - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

Gilead Sciences, Inc. (GILD) Wins FDA Approval for World’s First Twice-Yearly HIV Preventive Therapy - Yahoo Finance

Sep 02, 2025
pulisher
Sep 02, 2025

Pharming Group appoints Kenneth Lynard as Chief Financial Officer - GlobeNewswire Inc.

Sep 02, 2025
pulisher
Sep 02, 2025

Forecasting Gilead Sciences Inc. price range with options dataTake Profit & Real-Time Chart Breakout Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Gilead Sciences Inc. Recovery Likely Here’s What Data Shows getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 01, 2025
pulisher
Sep 01, 2025

Gilead Sciences’ SWOT analysis: HIV giant faces challenges, oncology promise - Investing.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is Gilead Sciences Inc. currently under institutional pressureTrade Entry Summary & Target Return Focused Picks - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Will Gilead Sciences Inc. bounce back from current supportRate Hike & Growth Oriented Trading Recommendations - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Will Gilead Sciences Inc. stock go up soonQuarterly Portfolio Review & Free High Return Stock Watch Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Technical analysis overview for Gilead Sciences Inc. stockQuarterly Profit Review & AI Based Buy and Sell Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Detecting support and resistance levels for Gilead Sciences Inc.Earnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Visual trend scoring systems applied to Gilead Sciences Inc.Fed Meeting & Fast Gain Stock Trading Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Gilead Sciences (GILD) Announces Marketing Authorization for Yeytuo from the European Commission - MSN

Aug 31, 2025
pulisher
Aug 30, 2025

Investors Hope for Bounce in Gilead Sciences Inc. After Selloff2025 Dividend Review & Weekly Setup with High ROI Potential - beatles.ru

Aug 30, 2025
pulisher
Aug 30, 2025

Price action breakdown for Gilead Sciences Inc.Earnings Overview Summary & Safe Entry Trade Signal Reports - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Paving the Way for the Future Pipeline: Gilead Builds New State-of-the-Art Research Center - Gilead Sciences

Aug 29, 2025
pulisher
Aug 29, 2025

Gilead Climbs 0.36% on Strong-Buy Upgrade and Institutional Buys Despite 174th-Ranked 0.52B Volume - AInvest

Aug 29, 2025
pulisher
Aug 29, 2025

Gilead Sciences' Insider Selling: Liquidity Management or Early Warning Signal? - AInvest

Aug 29, 2025
pulisher
Aug 29, 2025

Statistical indicators supporting Gilead Sciences Inc.’s strength2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Applying Wyckoff theory to Gilead Sciences Inc. stock2025 Geopolitical Influence & Advanced Technical Analysis Signals - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock - MSN

Aug 29, 2025
pulisher
Aug 29, 2025

Does Gilead Sciences Inc. show high probability of rebound2025 Technical Patterns & Risk Controlled Daily Trade Plans - Newser

Aug 29, 2025

Gilead Sciences Inc (GILD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general PFE
$24.91
price down icon 0.26%
$284.43
price down icon 0.37%
drug_manufacturers_general SNY
$49.91
price up icon 0.56%
drug_manufacturers_general NVO
$56.76
price up icon 0.64%
drug_manufacturers_general MRK
$85.09
price down icon 0.60%
大文字化:     |  ボリューム (24 時間):